Advanced Medical hit by euro weakness
Advanced Medical Solutions, the wound care specialist, has warned currency movements and the end of a rolling order are likely to hit full year revenues.
Advanced Medical Solutions, the wound care specialist, has warned currency movements and the end of a rolling order are likely to hit full year revenues.
AMS bought a German firm, RESORBA, in 2011, the effect being that more revenues are denominated in euros. The euro's current weakness means the company will see revenues decline when income is translated into sterling.
A "roll-stock" order for the group's foam product received in 2011 will not be repeated in 2012, further reducing turnover.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
In a statement to the company's AGM on Tuesday, however, AMS's Chairman Dr Don Evans stressed the revenue decline will only have a "negligible" effect on profits.
The stock was down 3.3% at 10:38.
BS
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
HMRC slaps pensioners with record high surprise tax bills - do you owe the taxman money?
More than a million people face surprise tax bills by HMRC, including thousands of pensioners, as triple lock pushes more retirees into taxable income brackets
-
Chase to launch its first ever credit card next month
Chase bank has been piloting its first-ever credit card to select employees and customers since November, but will roll it out to all customers from June, MoneyWeek can reveal. While the bank has become popular for current and savings accounts, will its credit offering be just as favoured?